Colin Fairchild
Colin Fairchild writes for Earno Review and other Independent Journal publications, covering earnings and corporate announcements and M&A, activist stakes and investment banks. Reporting under this byline is prepared by the Independent Journal editorial desk from primary sources, with AI assistance, and reviewed under our editorial policy.
6 articles

PAVmed Q3 earnings analysis: EsoGuard Medicare payments begin
PAVmed's preliminary third-quarter results show $1.2 million of EsoGuard revenue at Lucid Diagnostics, a $1.2 million adjusted loss and $8.9 million of cash.

Reddit's Weak Earnings Guidance Triggers Its Worst Day Ever
Reddit fell 29% after soft Q4 sales guidance and a planned login-wall test. What changed, who is affected, and what to watch as earnings season continues.
Microsoft Earnings Analysis: Strong Quarter Lifts Stock to a Record
Microsoft shares rose nearly 3% after hours into record territory following a quarter CNBC's Investing Club says validates the rebound. What it means and what's next.

Grupo Elektra Q3 Earnings Analysis: Ps.53.3B Revenue, Ps.7.8B EBITDA
Grupo Elektra reported Q3 2026 revenue of Ps.53,297 million and EBITDA of Ps.7,813 million. Our earnings analysis covers the margin and what to watch next.
Analyst Estimates and Consensus Explained: Beats, Misses, Revisions
How analyst estimates are built, how consensus is calculated and what a beat or miss compares. Covers research independence and company disclosure rules.
Citi Trends Guidance Raised After Q2 Comparable Sales Jump 10.5%
Citi Trends raised its fiscal 2026 outlook on August 25 after Q2 comparable sales rose 10.5%, while cutting planned new stores from 25 to 20. Our analysis.